David Hausner1,2,3, Colombe Tricou1,2,4, Jean Mathews1,2, Deepa Wadhwa5, Ashley Pope2, Nadia Swami2, Breffni Hannon1,2, Gary Rodin6,2,7, Monika K Krzyzanowska8,9, Lisa W Le10, Camilla Zimmermann1,6,2,7. 1. Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada. 2. Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. 3. Palliative Care Service, Chaim Sheba Medical Center, Ramat Gan, Israel. 4. Department of Palliative Care, Centre Hospitalier de Lyon-Sud, Hospices Civils de Lyon Pierre-Bénite, France. 5. BC Cancer - Kelowna, Kelowna, British Columbia, Canada. 6. Department of Psychiatry, University of Toronto, Toronto, Canada. 7. Princess Margaret Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. 8. Division of Medical Oncology, University of Toronto, Toronto, Canada. 9. Department of Medical Oncology and Hematology, University Health Network, Toronto, Canada. 10. Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Abstract
BACKGROUND: Evidence from randomized controlled trials has demonstrated benefits in quality of life outcomes from early palliative care concurrent with standard oncology care in patients with advanced cancer. We hypothesized that there would be earlier referral to outpatient palliative care at a comprehensive cancer center following this evidence. MATERIALS AND METHODS: Administrative databases were reviewed for two cohorts of patients: the pre-evidence cohort was seen in outpatient palliative care between June and November 2006, and the post-evidence cohort was seen between June and November 2015. Timing of referral was categorized, according to time from referral to death, as early (>12 months), intermediate (>6 months to 12 months), and late (≤6 months from referral to death). Univariable and multivariable ordinal logistic regression analyses were used to determine demographic and medical factors associated with timing of referral. RESULTS: Late referrals decreased from 68.8% pre-evidence to 44.8% post-evidence; early referrals increased from 13.4% to 31.1% (p < .0001). The median time from palliative care referral to death increased from 3.5 to 7.0 months (p < .0001); time from diagnosis to referral was also reduced (p < .05). On multivariable regression analysis, earlier referral to palliative care was associated with post-evidence group (p < .0001), adjusting for shorter time since diagnosis (p < .0001), referral for pain and symptom management (p = .002), and patient sex (p = .04). Late referrals were reduced to <50% in the breast, gynecological, genitourinary, lung, and gastrointestinal tumor sites. CONCLUSIONS: Following robust evidence from trials supporting early palliative care for patients with advanced cancer, patients were referred substantially earlier to outpatient palliative care. IMPLICATIONS FOR PRACTICE: Following published evidence demonstrating the benefit of early referral to palliative care for patients with advanced cancer, there was a substantial increase in early referrals to outpatient palliative care at a comprehensive cancer center. The increase in early referrals occurred mainly in tumor sites that have been included in trials of early palliative care. These results indicate that oncologists' referral practices can change if positive consequences of earlier referral are demonstrated. Future research should focus on demonstrating benefits of early palliative care for tumor sites that have tended to be omitted from early palliative care trials.
BACKGROUND: Evidence from randomized controlled trials has demonstrated benefits in quality of life outcomes from early palliative care concurrent with standard oncology care in patients with advanced cancer. We hypothesized that there would be earlier referral to outpatient palliative care at a comprehensive cancer center following this evidence. MATERIALS AND METHODS: Administrative databases were reviewed for two cohorts of patients: the pre-evidence cohort was seen in outpatient palliative care between June and November 2006, and the post-evidence cohort was seen between June and November 2015. Timing of referral was categorized, according to time from referral to death, as early (>12 months), intermediate (>6 months to 12 months), and late (≤6 months from referral to death). Univariable and multivariable ordinal logistic regression analyses were used to determine demographic and medical factors associated with timing of referral. RESULTS: Late referrals decreased from 68.8% pre-evidence to 44.8% post-evidence; early referrals increased from 13.4% to 31.1% (p < .0001). The median time from palliative care referral to death increased from 3.5 to 7.0 months (p < .0001); time from diagnosis to referral was also reduced (p < .05). On multivariable regression analysis, earlier referral to palliative care was associated with post-evidence group (p < .0001), adjusting for shorter time since diagnosis (p < .0001), referral for pain and symptom management (p = .002), and patient sex (p = .04). Late referrals were reduced to <50% in the breast, gynecological, genitourinary, lung, and gastrointestinal tumor sites. CONCLUSIONS: Following robust evidence from trials supporting early palliative care for patients with advanced cancer, patients were referred substantially earlier to outpatient palliative care. IMPLICATIONS FOR PRACTICE: Following published evidence demonstrating the benefit of early referral to palliative care for patients with advanced cancer, there was a substantial increase in early referrals to outpatient palliative care at a comprehensive cancer center. The increase in early referrals occurred mainly in tumor sites that have been included in trials of early palliative care. These results indicate that oncologists' referral practices can change if positive consequences of earlier referral are demonstrated. Future research should focus on demonstrating benefits of early palliative care for tumor sites that have tended to be omitted from early palliative care trials.
Keywords:
Cancer; Early medical intervention; Health care quality, access and evaluation; Health services accessibility; Health services research; Outcome assessment, healthcare; Outpatient clinics, hospital; Palliative care
Authors: C B Smith; J E Nelson; A R Berman; C A Powell; J Fleischman; J Salazar-Schicchi; J P Wisnivesky Journal: Ann Oncol Date: 2011-07-29 Impact factor: 32.976
Authors: Anna Sorensen; Kirsten Wentlandt; Lisa W Le; Nadia Swami; Breffni Hannon; Gary Rodin; Monika K Krzyzanowska; Camilla Zimmermann Journal: Support Care Cancer Date: 2019-06-04 Impact factor: 3.603
Authors: David Hui; Masanori Mori; Yee-Choon Meng; Sharon M Watanabe; Augusto Caraceni; Florian Strasser; Tiina Saarto; Nathan Cherny; Paul Glare; Stein Kaasa; Eduardo Bruera Journal: Support Care Cancer Date: 2017-07-19 Impact factor: 3.603
Authors: Roni Nitecki; Elisabeth J Diver; Mihir M Kamdar; David M Boruta; Marcela C Del Carmen; Rachel M Clark; Annekathryn Goodman; John O Schorge; Whitfield B Growdon Journal: Gynecol Oncol Date: 2018-02-12 Impact factor: 5.482
Authors: Areej El-Jawahri; Joseph A Greer; William F Pirl; Elyse R Park; Vicki A Jackson; Anthony L Back; Mihir Kamdar; Juliet Jacobsen; Eva H Chittenden; Simone P Rinaldi; Emily R Gallagher; Justin R Eusebio; Sarah Fishman; Harry VanDusen; Zhigang Li; Alona Muzikansky; Jennifer S Temel Journal: Oncologist Date: 2017-09-11
Authors: Inmaculada Valero-Cantero; Cristina Casals; Yolanda Carrión-Velasco; Francisco Javier Barón-López; Francisco Javier Martínez-Valero; María Ángeles Vázquez-Sánchez Journal: BMC Palliat Care Date: 2022-02-28 Impact factor: 3.234
Authors: Katharine Weetman; Jeremy Dale; Sarah J Mitchell; Claire Ferguson; Anne M Finucane; Peter Buckle; Elizabeth Arnold; Gemma Clarke; Despoina-Elvira Karakitsiou; Tracey McConnell; Nikhil Sanyal; Anna Schuberth; Georgia Tindle; Rachel Perry; Bhajneek Grewal; Katarzyna A Patynowska; John I MacArtney Journal: BMC Palliat Care Date: 2022-09-06 Impact factor: 3.113
Authors: Lee A Hugar; Elizabeth M Wulff-Burchfield; Gary S Winzelberg; Bruce L Jacobs; Benjamin J Davies Journal: Nat Rev Urol Date: 2021-07-26 Impact factor: 14.432